Solventum Names Parag Kachalia Global Clinical Evidence Director
New role will focus on clinical strategy supporting the company’s digital dental solutions.
-
By
-
News Staff
-
September 28, 2026
Clinical Scorecard: Solventum Names Parag Kachalia Global Clinical Evidence Director
At a Glance
| Category | Detail |
|---|
| Condition | Clinical topic addressed by the source article: Solventum Names Parag Kachalia Global Clinical Evidence Director |
| Key Mechanisms | Mechanisms or clinical associations described in the source article. |
| Target Population | Patients or participants described in the source article. |
| Care Setting | Specify the type of digital dental solutions. |
Key Highlights
- Parag Kachalia appointed as global clinical evidence director.
- 25 years of experience in clinical practice and dental technology.
- Former head of clinical practice at Overjet.
- Recognized in Incisal Edge’s 32 Most Influential People in Dentistry.
- Focus on developing digital workflows for diagnostic accuracy.
Guideline-Based Recommendations
Diagnosis
- Include any relevant diagnostic guidelines if applicable.
Management
- Include any relevant management guidelines if applicable.
Monitoring & Follow-up
- Include any relevant monitoring guidelines if applicable.
Risks
- Include any relevant risk guidelines if applicable.
Patient & Prescribing Data
Specify the target patient demographics if available.
Clinical Best Practices
- Utilization of artificial intelligence in clinical workflows.
- Integration of academic research into clinical practice.
Related Resources & Content
